N-Acetylglucosaminyltransferase V (GnT-V), catalyzing β1-6 branching in asparagine-linked oligosaccharides, is one of the most important glycosyltransferases involved in tumor metastasis and carcinogenesis. Although the expression of GnT-V is induced in chronic liver diseases, the biological meaning of GnT-V in the diseases remains unknown. The aim of this study was to investigate the effects of GnT-V on the progression of chronic hepatitis, using GnT-V transgenic (Tg) mice fed a high fat and high cholesterol (HFHC) diet, an experimental model of murine steatohepatitis. Although enhanced hepatic lymphocytes infiltration and fibrosis were observed in wild-type (WT) mice fed the HFHC diet, they were dramatically prevented in Tg mice. In addition, the gene expression of inflammatory Th1 cytokines in the liver was significantly decreased in Tg mice than WT mice. Inhibition of liver fibrosis was due to the dysfunction of hepatic stellate cells (HSCs), which play pivotal roles in liver fibrosis through the production of transforming growth factor (TGF)-β1. Although TGF-β1 signaling was enhanced in Tg mouse-derived HSCs (Tg-HSCs) compared with WT mouse-derived HSCs (WT-HSCs), collagen expression was significantly reduced in Tg-HSCs. As a result from DNA microarray, cyclooxygenase-2 (COX2) expression, known as a negative feedback signal for TGF-β1, was significantly elevated in Tg-HSCs compared with WT-HSCs. Prostaglandin E2 (PGE2), the product of COX2, production was also significantly elevated in Tg-HSCs. COX2 inhibition by celecoxib decreased PGE2 and increased collagen expression in Tg-HSCs. In conclusion, GnT-V prevented steatohepatitis progression through modulating lymphocyte and HSC functions.
Introduction
Recent findings in glycobiology revealed the direct evidence of the involvement of oligosaccharide changes in human diseases (Ohtsubo and Marth 2006) . The branching formation of N-glycans is one of the most important factors to regulate biological functions of oligosaccharides in human diseases and is regulated by several kinds of N-acetylglycosyltransferases (Zhao et al. 2008) . N-Acetylglucosaminyltransferase V (GnT-V, gene name; Mgat5) is involved in the synthesis of β1-6GlcNAc formation on N-glycans, resulting in increases in the branching formation of N-glycan (Taniguchi et al. 1999) . It is well known that GnT-V is one of the most important glycosyltransferases involved in cancer metastasis (Lau and Dennis 2008) . GnT-V promotes cancer metastasis through the enhancement of growth factor signaling, integrin functions and expression of certain kinds of proteases (Taniguchi et al. 1999 (Taniguchi et al. , 2001 Lau and Dennis 2008) . A study of GnT-V knockout mice also revealed the importance of GnT-V as negative regulators of lymphocytes through modification of T cell receptor oligosaccharides (Demetriou et al. 2001) .
In contrast, expression of GnT-V in the normal liver is quite low, but is increased in chronic hepatitis and regenerating liver (Miyoshi et al. 1993 (Miyoshi et al. , 1995 . These results indicate that the up-regulation of GnT-V is the early event of carcinogenesis. GnT-V knockout mice suppressed tumor formation and metastasis after mating with transgenic (Tg) mice of spontaneous cancer development, suggesting that GnT-V is essential in the tumor growth as well as metastasis (Granovsky et al. 2000) . To know the direct involvement of GnT-V in carcinogenesis, we have recently established GnT-V Tg mice under control of β-actin promoter (Terao et al. 2011) . Although no tumor formation was observed in all organs of GnT-V Tg at 1-2 years after birth, enhanced epithelial-mesenchymal transition (EMT) in the skin was observed. Since EMT is a possible event to induce cancer/ cancer metastasis, these data prompted us to induce hepatic injury in GnT-V Tg.
Non-alcoholic fatty liver disease (NAFLD) is among the most common causes of chronic liver disease (CLD) in the world, and a growing medical problem in industrialized countries (Ford et al. 2002) . A wide spectrum of histological changes has been observed in NAFLD, ranging from simple steatosis, which is generally non-progressive, to non-alcoholic steatohepatitis (NASH), and a proportion of patients with NASH develops cirrhosis and hepatocellular carcinoma (Bugianesi et al. 2002) . Recent studies indicate that dietary cholesterol is an important risk factor for the progression of NASH in both human and rodents (Matsuzawa et al. 2007; Yasutake et al. 2009 ). In addition, cholesterol lowering drugs, such as statins and ezetimibe, were reported to improve NASH progression (Deushi et al. 2007; Hyogo et al. 2008) .
In the present study, we treated GnT-V Tg with a high fat and high cholesterol (HFHC) diet and found that overexpression of GnT-V suppressed the development of NASH such as lymphocyte infiltration and liver fibrosis. A possible mechanism was investigated with in vitro experiments, using HSCs in primary culture.
Results
Hepatic injury was attenuated in GnT-V Tg mice compared with wild-type mice fed with the HFHC diet The body weight was significantly higher in Tg mice than in wild type (WT) ones fed with the normal chow (NC) diet (Table I ). In the NC diet-fed mice, the liver weight and liver-to-body weight ratio were significantly higher in Tg ones than in WT ones. In contrast, the liver weight and liver-to-body weight ratio were significantly lower in Tg mice than WT mice fed with the HFHC diet. There were no differences in the serum triglyceride (TG) and cholesterol levels, and liver TG levels between WT and Tg mice fed with the NC and HFHC diets, respectively. There were also no differences in the liver cholesterol contents between Tg and WT mice fed with the NC diet. However, the liver cholesterol levels were significantly lower in Tg mice than in WT ones fed with the HFHC diet.
There were no significant differences in the liver histology between Tg and WT mice fed with the NC diet. However, when mice were fed with the HFHC diet for 4 weeks, the number of infiltrated inflammatory cells in the livers was significantly decreased in Tg mice compared with WT mice ( Figure 1A ). The majority of these inflammatory cells in the mice livers fed the HFHC diet were CD4-and CD8-positive lymphocytes (data not shown). Serum alanine aminotransferase (ALT) levels were also lower in Tg mice than WT mice fed the HFHC diet ( Figure 1B) .
Next, we investigated gene expressions of inflammationrelated cytokines and chemokines in the mouse livers. When the mice were feeding the NC diet, there were no significant differences in these hepatic gene expression changes. The HFHC diet feeding greatly increased liver inflammatory gene expressions in WT mice. As it was reported that naïve T cells from Mgat5 (GnT-V) knockout mice produce more Th1 cytokines compared with WT cells (Morgan et al. 2004) , we investigated the typical Th1 cytokines gene [interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and IL-1β] expression in the mice livers. We also investigated hepatic nitric oxide synthase 2 (NOS2) and monocyte chemoattractant protein-1 (MCP-1) (CCL2) gene expressions, which are induced by inflammatory stimulation in the NASH liver (Haukeland et al. 2006; Gao et al. 2008) . In Tg mice, the inflammatory gene expressions were significantly decreased, compared with WT mice fed with the HFHC diet ( Figure 1C ).
Liver fibrosis was attenuated in GnT-V Tg mice compared with WT mice on the HFHC diet To assess liver fibrosis on the HFHC diet, hepatic collagen deposition was evaluated by picrosirius red staining of liver sections. Liver collagen deposition was not different between WT and Tg mice fed with the NC diet, but significantly lower in Tg mice than WT mice fed the HFHC diet (Figure 2A and B) . Moreover, hepatic fibrogenic mRNA levels, such as transforming growth factor (TGF)-β, plateletderived growth factor (PDGF) and collagen Iα1, were significantly lower in Tg mice than in WT mice fed the HFHC diet ( Figure 2C ). 
Role of GnT-V in steatohepatitis progression
Excess expression of GnT-V enhanced β1-6GlcNAc branching of N-glycans in Tg-HSCs L4-PHA binds to the β1-6GlcNAc branching of N-glycans, which is the product of GnT-V. To investigate the difference of GnT-V and β1-6GlcNAc branching of N-glycans expression in the liver, primary cultured hepatocyte and HSC from GnT-V Tg and WT mice, GnT-V immunoblotting and L4-PHA lectin blotting were performed ( Figure 3A -C). GnT-V protein expression was scarcely expressed in WT-HSCs but was increased in Tg-HSCs ( Figure 3C , upper panel). The expression of β1-6GlcNAc branching of N-glycans (80-200 kDa band) as judged from L4-PHA lectin blotting was significantly increased in Tg-HSCs compared with WT-HSCs ( Figure 3C , lower panel, asterisk). In contrast, the expression of GnT-V was quite low in the livers and hepatocytes in Tg and WT mice ( Figure 3A and B, upper panel). Levels of β1-6GlcNAc branching on N-glycans were not different despite the aberrant expression of GnT-V. A few differences of L4-PHA bindings in each lane (the liver) might be due to serum contamination.
GnT-V enhanced TGF-β signaling but decreased collagen I expression in Tg-HSCs To investigate the effect of GnT-V on HSC, we treated WT-HSCs and Tg-HSCs with TGF-β1 (1 ng/mL) and examined fibrosis-related gene expression changes by reverse transcription-polymerase chain reaction (RT-PCR). Treatment of both WT-HSCs and Tg-HSCs with TGF-β1 significantly increased TGF-β1, PDGF and collagen Iα1 expressions. The expression of TGF-β1 and PDGF was increased after 6 h TGF-β1 stimulation and decreased after 30 h. The expression of collagen Iα1 was increased after 6 h in both Tg-HSCs and WT-HSCs and further increased in Tg-HSCs after 30 h.
Tg-HSCs showed higher expression levels of TGF-β1 and PDGF with or without TGF-β1 than WT-HSCs ( Figure 4A and B). Surprisingly, Tg-HSCs showed a lower expression level of collagen Iα1 than WT-HSCs with or without TGF-β1 ( Figure 4C ). To investigate the effect of GnT-V on TGF-β1 signaling in mice HSC, we checked Smad3 nuclear translocation in WT-HSCs and Tg-HSCs after TGF-β1 stimulation ( Figure 4D ). We could not detect Smad3 nuclear translocation clearly in WT-HSCs after 1 ng/mL of TGF-β1 stimulation (data not shown), so we used 5 ng/mL of TGF-β1 in this investigation. Smad3 protein expression in cytoplasmic extracts of HSCs was decreased after TGF-β1 stimulation, and TGF-β1 stimulation significantly increased nuclear Smad3 protein levels in WT-HSCs and Tg-HSCs. Interestingly, nuclear Smad3 protein levels were significantly higher in Tg-HSCs than WT-HSCs before and after TGF-β1 stimulation. These results indicated that TGF-β1 signaling in mice HSC was enhanced in GnT-V Tg mice. The mRNA expression levels were normalized relative to the level of GAPDH mRNA expression and expressed in arbitrary units. For all panels, white columns indicate WT mice data, and black columns indicate GnT-V Tg mice data. Results are the mean ± SEM (n = 5); **P < 0.01 and *P < 0.05 vs. WT mice fed with the HFHC diet group.
To determine whether the structures of sugar chains were changed by the increased GnT-V, we further carried out L4-PHA blot analysis using membrane fractions of HSCs ( Figure 4E ). The expression of β1-6GlcNAc branching of N-glycans on cell membrane (80-200 kDa band) was increased in Tg-HSCs before TGF-β1 stimulation compared with WT-HSCs. The expression of β1-6GlcNAc branching of N-glycans was elevated after 15 h TGF-β1 stimulation in both WT-HSCs and Tg-HSCs, and its expression was still higher in Tg-HSCs than WT-HSCs. Polylactosamine structures on β1-6GlcNAc branching of N-glycans are recognized by endogenous lectins, such as galectins (Lee and Lee 2000; Partridge et al. 2004) , and it was also reported that membrane galectins form lattices and lattices forming can inhibit growth factor receptors endocytosis, including TGF-β receptor (Demetriou et al. 2001; Partridge et al. 2004) . As expected, weak galectin-3 expression was observed in WT-HSCs, and the expression was elevated in Tg-HSCs compared with WT-HSCs with or without TGF-β1 stimulation. TGF-β1 stimulation elevated cell surface TGF-βR(II) expression in WT-HSCs. In Tg-HSCs, membrane TGF-βR(II) expression was enhanced before TGF-β1 stimulation compared with WT-HSCs, and further elevated after TGF-β1 stimulation. Elevated galectin-3 should inhibit TGF-βR(II) endocytosis, and TGF-βR(II) elevation up-regulated TGF-β1 signaling in Tg-HSCs.
Cyclooxygenase-2 gene expression and prostaglandin E2 production were elevated in GnT-V Tg-HSCs compared with WT-HSCs before and after TGF-β1 stimulation To investigate the discrepancy between enhanced TGF-β1 signaling and decreased collagen gene expression in mice HSC, we performed DNA microarray analysis between Tg and WT-HSCs (Supplementary data, Table SI). We showed top 30 higher genes in Tg-HSCs than in WT-HSCs. Among various elevated genes, cyclooxygenase-2 (COX2; Ptgs2) is known for the rate-limiting enzyme in prostaglandin E2 (PGE2) production, and COX2-derived PGE2 inhibited TGF-β1-induced collagen production in HSCs as a negative feedback signal (Hui et al. 2004) . To investigate the effect of GnT-V on COX2 gene expression of HSCs, we checked COX2 gene expression before and after TGF-β1 stimulation in WT-HSCs and Tg-HSCs by real-time RT-PCR ( Figure 5A ). Treatment of WT-HSCs and Tg-HSCs with TGF-β1 significantly increased COX2 expressions. Before and after TGF-β1 stimulation, COX2 gene expression was elevated in Tg-HSCs compared with WT-HSCs. In addition, TGF-β1-induced PGE2 production was significantly elevated in Tg-HSCs compared with WT-HSCs ( Figure 5B) . A selective COX2 inhibitor, celecoxib, treatment significantly decreased PGE2 production and significantly elevated collagen I gene expression in Tg-HSCs ( Figure 5C and D) .
Discussion
In the present study, we found that murine steatohepatitis progression induced by HFHC diet feeding was prevented in GnT-V Tg mice compared with WT mice. While the enhanced hepatic lymphocytes infiltration and fibrosis were observed in WT mice fed with the HFHC diet, they were dramatically prevented in Tg mice fed with the HFHC diet. Since GnT-V is one of the most important glycosyltransferases involved in carcinogenesis, this result was unexpected. In GnT-V Tg mice fed the HFHC diet, suppression of lymphocytes infiltration was due to a decrease in inflammatory Th1 cytokines in the liver. Inhibition of liver fibrosis in Tg mice was due to the dysfunction of HSCs. In HSCs from GnT-V Tg mice, although TGF-β signaling was enhanced, collagen expression was suppressed. Fig. 3 . β1-6GlcNAc structures were increased in GnT-V Tg-HSCs, but not in hepatocytes and the liver. Expression of GnT-V in the liver (A), hepatocyte (B) and whole cell lysates of HSCs (C) were characterized by immunoblot against GnT-V (upper panel). The amount of β1-6GlcNAc branching (the product of GnT-V) was assessed by L4-PHA lectin blot analysis in the liver (A), hepatocyte (B) and whole cell lysates of HSCs (C) (middle panel). Immunoblot against GAPDH (lower panel) was performed as a loading control. Asterisks indicate several β1-6GlcNAc oligosaccharide-containing glycoproteins. Arrows indicate the non-specific bands. The 75-and 130-kDa bands on the blots appear to be non-specific because they are also detected by the avidin-horseradish peroxidase conjugate alone. WT liver, the WT mice liver; Tg-liver, GnT-V Tg mice liver; WT-hepatocyte, WT mouse-derived hepatocyte; Tg-hepatocyte, Tg mouse-derived hepatocyte; HSC, hepatic stellate cell; WT-HSCs, WT mouse-derived HSCs; Tg-HSCs, GnT-V Tg mouse-derived HSCs; WB, western blot analysis; LB, lectin blot analysis.
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Our study showed that enhanced PGE2 production by elevated COX2 would decrease collagen expression in Tg-HSCs. These findings indicated that GnT-V could prevent steatohepatitis progression in mice.
Growth factor receptors, including TGF-β receptor, are generally N-glycosylated transmembrane proteins, and residency at the cell surface is dependent in part on the dynamics of membrane remodeling. Endogenous lectins, such as galectins, generated by N-glycan branching can cross-link glycoproteins at the cell surface forming lattices, and galectin binding opposes the loss of receptors to endocytosis (Lee and Lee 2000) . Increased cell surface TGF-β receptor is known to enhance the sensitivity to TGF-β1. In GnT-V (Mgat5) knockout tumor cells, cell surface galectin-3 and sensitivity to TGF-β1 was reduced, and chemical endocytosis inhibitor restored the sensitivity to TGF-β1 (Partridge et al. 2004 ). These findings indicated that galectin forming lattice blocked TGF-β receptor endocytosis and enhanced TGF-β signaling Fig. 4 . GnT-V enhanced TGF-β signaling but decreased collagen I expression in GnT-V Tg-HSCs. (A-C) Gene expressions in HSCs before and after TGF-β1 stimulation. GnT-V Tg-HSCs and WT-HSCs were stimulated with 1 ng/mL of TGF-β1 for indicated times. HSC gene expressions were assessed using real-time RT-PCR. The mRNA expression levels were normalized relative to the level of GAPDH mRNA expression and expressed in arbitrary units. For all panels, white columns indicate WT mice data, and black columns indicate GnT-V Tg mice data. Results are the mean ± SEM (n = 5); **P < 0.01 and *P < 0.05, vs. the WT-HSC group. (D) The nuclear translocation of Smad3 in HSCs before and after stimulation with TGF-β1. Nuclear (upper panel) and cytoplasmic (lower panel) extracts of HSCs were used for immunoblotting of Smad3 before and 30 min after TGF-β1 (5 ng/mL) stimulation. Immunoblots against histone H3 and GAPDH were performed as loading controls. (E) GnT-V elevated protein expression of membrane β1-6GlcNAc branching of N-glycans, galectin-3 and TGF-βR (II) in activated HSCs. Tg-HSCs and WT-HSCs were stimulated with 5 ng/mL of TGF-β1 for 15 h. The membrane protein of HSCs was extracted and used for immunoblotting. The amount of β1-6GlcNAc branching (the product of GnT-V) was assessed by L4-PHA lectin blot analysis. Immunoblot against EGFR was performed as a loading control. Asterisk indicates several β1-6GlcNAc oligosaccharide-containing glycoproteins. Arrow indicates the non-specific band. Membrane galectin-3 protein and TGF-βR(II) protein expression were evaluated by immunoblotting.
Role of GnT-V in steatohepatitis progression (Partridge et al. 2004) . As expected, galectin-3 expression and TGF-β signaling (Smad3 nuclear translocation) was enhanced in membrane fractions of HSCs from GnT-V Tg before and after TGF-β stimulation in the present study. As a result, TGF-β1 target gene expressions of TGF-β and PDGF were elevated in Tg-HSCs compared with WT-HSCs. However, collagen Iα1 gene expression, also known for one of TGF-β1 target genes, was significantly lower in Tg-HSCs than in WT-HSCs before and after TGF-β1 stimulation. Furthermore, hepatic fibrosis was attenuated in Tg mice compared with WT mice in vivo. To investigate the reason why collagen expression was decreased in Tg-HSCs in spite of the enhanced TGF-β signaling, we performed microarray analysis between Tg-HSCs and WT-HSCs. Among various elevated genes, COX2 expression was significantly elevated in Tg-HSCs compared with WT-HSCs. COX2 is a rate-limiting enzyme in PGE2 production. It was reported that TGF-β1 stimulated COX2 expression, and COX2-derived PGE2 inhibited TGF-β1-induced collagen production in HSCs as a negative feedback signal (Hui et al. 2004) . In this study, celecoxib, a selective COX2 inhibitor, treatment decreased PGE2 production and up-regulated collagen I gene expression in Tg-HSCs. GnT-V-induced continuous TGF-β1 stimulation should enhance COX2 expression, and this negative feedback signal could reduce collagen expression in the Tg mice liver and Tg-HSCs. The precise mechanism for this is under investigation.
TGF-β1 is widely known as an inhibitor of cell proliferation, cell cycle, and activated T cells (Massague 2000; Park et al. 2006; Li and Flavell 2008; Yoshimura et al. 2010) . These effects of TGF-β1 should decrease T-cell activation and proliferation and lead to ameliorate steatohepatitis progression in this study. In addition, β1-6GlcNAc branching of N-glycans on T-cell antigen receptor (TCR) bind galectins, forming a multivalent lattice that inhibits TCR recruitment into the immune synapse (Demetriou et al. 2001) , indicating an inhibitory role for β1-6GlcNAc branching of N-glycans in TCR signaling. Moreover, it was reported that naïve T cells from GnT-V knockout mice produce more Th1 cytokines (inflammatory) and less Th2 cytokines (anti-inflammatory) compared with WT cells (Morgan et al. 2004 ). Agonist-induced TCR clustering was enhanced in GnT-V-deficient T cells, which lowered the threshold for TCR-dependent tyrosine phosphorylation. Consequently, GnT-V knockout mice increased susceptibility to autoimmune diseases (Demetriou et al. 2001 ). In addition, expression of β1-6GlcNAc branching of N-glycans selectively inhibits Th1 cell differentiation and enhances the polarization of Th2 cells (Morgan et al. 2004 ). In the present study, Th1 cytokines, such as IFN-γ, TNF-α, IL-6 and IL-1β, were decreased in the GnT-V Tg mice liver fed with the HFHC diet compared with WT mice fed with the HFHC diet. These results indicated that β1-6GlcNAc branching of N-glycans suppressed Th1 polarization in GnT-V Tg mice and reduced inflammatory cell infiltration in the Tg mice liver.
In conclusion, GnT-V prevented hepatic inflammation and fibrosis in a mice steatohepatitis model through modulating lymphocyte and HSC functions. The enhanced expression of GnT-V in CLDs might protect disease progression as a selfdefense reaction.
Materials and Methods
Animal experiments All experimental protocols described in this study were approved by the Ethics Review Committee for Animal Experimentation of Osaka University School of Medicine.
GnT-V (Mgat5) Tg mice were prepared as described (Terao et al. 2011) . WT mice were purchased from Oriental Yeast (Suita, Osaka, Japan). The animals were provided with unrestricted amounts of food and water, housed in temperatureand humidity-controlled rooms and maintained on a 12/12 h light/dark cycle. The HFHC (containing 15% cocoa butter fat, 1.25% cholesterol and 0.5% cholic acid) and NC diets were purchased from Oriental Yeast.
To determine the role of GnT-V in HFHC diet-induced liver injury, WT and Tg mice (age, 7-9 weeks; sex, male) were assigned to the NC or HFHC diet for 4 weeks. At the end of the experimental period, food was withdrawn for a minimum of 5 h and then the mice were sacrificed. Blood was collected aseptically from the inferior vena cava and centrifuged (2000 g, 7 min, 4°C), and the serum was collected. The liver was either fixed with 10% buffered paraformaldehyde or embedded in compound and frozen at −80°C for histological examination, or immediately frozen in liquid nitrogen for protein and mRNA extraction.
H&E staining and picrosirius red staining Liver sections were stained with H&E or picrosirius red (Sigma-Aldrich, St Louis, MO). The fibrotic area as a percentage was calculated using image analysis software (winROOF visual system; Mitani Co., Tokyo, Japan).
Determination of gene expression levels
Total RNAs were extracted from whole livers or HSCs with QIAshredder and an RNeasy Mini Kit according to the instructions provided by the manufacturer (Qiagen, Hilden, Germany), and then transcribed into complementary DNA with a Quantitect Reverse Transcription Kit (Qiagen). Quantitative real-time RT-PCR was performed with a QuantiFast SYBR Green PCR Kit using specific primers (Qiagen) on a LightCycler according to the instructions provided by the manufacturer (Roche Diagnostics, Indianapolis, IN). The primers used were IFN-γ (QT01038821), TNF-α (QT00104006), IL-6 (QT00098875), IL-1β (QT01048355), NOS2 (QT00100275), MCP-1 (QT00167832), TGF-β1 (QT00145250), PDGF (QT00266910), collagenIα1 (QT00162204), COX2 (QT00165347) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; QT00199388) (Qiagen). The mRNA expression levels were normalized as to the GAPDH mRNA expression level and expressed in arbitrary units.
Isolation and culture of mouse hepatocytes and HSCs
Hepatocytes and HSCs were isolated from WT (WT-HSCs) and Tg (Tg-HSCs) mice by two-step collagenase-pronase perfusion of their livers as described previously (Kristensen et al. 2000) . Briefly, the livers were perfused for 10 min at room temperature at a flow rate of 3 mL/min with an SC-1 solution [8000 mg/L NaCl, 400 mg/L KCl, 78 mg/L NaH 2 PO 4 2H 2 O, 151 mg/L Na 2 HPO 4 12H 2 O, 2380 mg/L 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 350 mg/L NaHCO 3 , 190 mg/L ethylene glycol tetraacetic acid, 900 mg/ L glucose, pH 7.2], followed by digestion at 37°C for 10 min with 0.053% pronase and 0.027% collagenase dissolved in an SC-2 solution (8000 mg/L NaCl, 400 mg/L KCl, 78 mg/L NaH 2 PO 4 2H 2 O, 151 mg/L Na 2 HPO 4 12H 2 O, 2380 mg/L HEPES, 350 mg/L NaHCO 3 , 735 mg/L CaCl 2 2H 2 O, pH 7.5). Each digested liver was excised and cut into small pieces. The resulting suspension was filtered through a 100-μm cell strainer and centrifuged at 50 × g for 1 min at 4°C to obtain hepatocytes. This protocol was repeated three times and then the supernatants were centrifuged at 2000 rpm for 7 min at 4°C
. The pellet was washed, suspended in Dulbecco's modified Eagle's medium (DMEM) two times and then plated on a plastic culture dish. The isolated HSCs were maintained at 37°C under 5% CO 2 in DMEM containing 10% fetal calf serum. Isolated hepatocytes were used for further investigation, and HSCs after a few passages were used for the experiments.
HSCs were stimulated with 1 ng/mL of TGF-β1 (Peprotech, Rocky Hill, NJ) for the indicated times. Tg-HSCs were stimulated with 10 mM celecoxib [kindly donated by Phizer Pharmaceuticals (New York, NY)] for the indicated times. RNA extraction and RT-PCR were performed as described in the Determination of gene expression levels section.
Western and lectin bolt analyses
Approximately 10 mg of frozen liver tissue was lysed with a lysis buffer [10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS)]. Isolated mouse hepatocytes were lysed with 1% Triton X-100. For the immunoblotting of nuclear Smad3, HSCs were stimulated with 5 ng/mL of TGF-β1 for 30 min. The nuclear and cytoplasmic proteins of HSCs were extracted and used for immunoblotting of Smad3. For the immunoblotting of TGF-βR(II) and galectin-3, HSCs were stimulated with TGF-β1 (5 ng/mL) for the indicated times. The membrane protein of HSCs was extracted and used for immunoblotting. For lectin blotting of L4-PHA, HSCs were stimulated with TGF-β1 (5 ng/mL) for the indicated times. The membrane proteins of HSCs were extracted and used. Whole cell lysates were prepared by using 1% Triton X-100. A cellular membrane fraction was prepared with Mem-PER (PIERCE, Rockford, IL), according to the manufacturer's instructions. For nuclear and cytoplasmic extracts, cells were lysed in NE-PER extraction reagent (PIERCE) according to the manufacturer's protocol. Samples were then subjected to heat denaturation at 98°C for 5 min. The samples (10-30 μg of protein) were subjected to SDS-polyacrylamide gel electrophoresis and then transferred to a polyvinylidene fluoride membrane. The membrane was subsequently treated with 5% skim milk for western blotting and 3% bovine serum albumin for lectin blotting. Then, for immunodetection, the following antibodies were used: anti-Smad3 antibodies (Cell Signaling Technology, Beverly, MA), anti-TGF-βR(II) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA), anti-galectin-3 antibodies (American Qualex Inc., San Clemente, CA), anti-GnT-V antibody 24D11 (Fujirebio, Tokyo, Japan), L4-PHA lectin (J-Oil Mills Inc. Tokyo, Japan), anti-histon H3 antibody (Cell Signaling Technology), anti-epidermal growth factor receptor (EGFR) antibody (Cell Signaling Technology) and anti-GAPDH antibody (Trevigen, Gaithersburg, MD). Immunoreactive bands were visualized on GE Healthcare film by using ECL detection reagent (GE Healthcare, Waukesha, WI).
PGE2 measurement
PGE2 secreted by HSCs in the presence of TGF-β1 was quantitated using a PGE2 ELISA Kit (Invitrogen, Carlsbad, CA), according to the manufacturer's instructions. HSCs (3 × 10 cells) were cultured in 12-well culture plates overnight and then stimulated with 1 ng/mL of TGF-β1 for 6 h. Then culture supernatants were collected for analysis. Cytokine levels were expressed as the mean ± SEM for 3 × 10 5 cells. The hybridization process was performed according to the manufacturer's instructions, and hybridized microarrays were scanned using an Agilent Microarray Scanner. Agilent's Feature Extraction software was used for the image analysis and data extraction processes.
Statistical analysis
The results are presented as the mean ± SEM. Analysis of variance for the groups was performed by means of the Kruskal-Wallis test, followed by the Scheffe test for multiple comparisons to allow pairwise testing for significant differences between groups. Statistical significance was defined as P < 0.05.
